Tag Archives: Biogen

Is this worth taking?

December 12, 2022 Roy A. Ackerman, Ph.D., E.A.

Lecanemab.

Is it really working?

So, the data seems to indicate that administering this drug will retard cognitive and functional decline by 27%, when compared to a placebo. That’s good news for Eisai and Biogen- as well as perhaps for Eli Lilly which is concurrently testing its own anti-amyloid drug for Alzheimer’s.

Continue reading Is this worth taking? →

Hope or Chimera for Alzheimer’s Patients?

June 17, 2021 Roy A. Ackerman, Ph.D., E.A. 3 Comments

Hmm. Is this good news or not?

The FDA (Food and Drug Administration) has just approved aducanumab (Aduhelm) for Alzheimer’s. Of course, if you are Biogen, this is great news. But, since the data is – how do I say this?- less than emphatic- will this really help patients?

Continue reading Hope or Chimera for Alzheimer’s Patients? →